The observed increase in ratio of SK1 to CERS2 expression in COVID-19 and convalescent samples compared to the control suggests alterations in the sphingolipid rheostat with COVID-19 infection and a potential role for this pathway in survival and turnover of both structural and immune cells in the lungs post-infection. This evidence concerns the gene CERS2 and COVID-19.